m+Medelevator.RU
← Поиск публикаций
Pharmacological research · 2026

Unraveling MARCH6's role in cancer progression and metabolism from protein homeostasis to oncogenesis.

СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Zhen Yumiao, Chen Shiji, Niu Bo, Wang Yitao, Leung Chung-Hang, Zhong Hai-Jing

Аннотация

Malignant neoplasms are a leading cause of morbidity and mortality globally, with rising rates despite advancements in detection and treatment. This review examines the multifaceted role of MARCH6, an endoplasmic reticulum-resident E3 ubiquitin ligase, in cancer biology and disease regulation. MARCH6 exhibits a complex, context-dependent dual role: it functions as a pro-oncogenic driver in papillary thyroid carcinoma (PTC) and hepatocellular carcinoma (HCC), where it promotes cell proliferation and metastatic potential, yet simultaneously serves protective roles in non-malignant pathological conditions, including the regulation of ferroptosis, a form of iron-dependent lipid peroxidation-driven cell death, and antiviral immunity. In particular, emerging evidence suggests that MARCH6 can modulate ferroptosis through the selective degradation of key regulators such as p53 and ACSL4, thereby linking ubiquitin-mediated proteostasis to redox balance and lipid metabolism. The review synthesizes current understanding of MARCH6's structure, substrate specificity, and tissue-specific functional outcomes, emphasizing the molecular determinants of its context-dependent activity across different cellular contexts. Particular attention is given to MARCH6's regulatory impact on cholesterol and lipid metabolism, oxidative stress responses, and cell death mechanisms, with ferroptosis positioned as a central mechanistic axis through which MARCH6 may influence tumor progression and therapeutic response. Despite these mechanistic advances, critical knowledge gaps persist regarding substrate selectivity across diverse cancer types, the molecular basis of functional polarity, and therapeutic feasibility. This synthesis aims to guide future research toward harnessing MARCH6's potential as a biomarker and selective therapeutic target in cancer and stress-related diseases, particularly in the context of ferroptosis modulation, while acknowledging the inherent challenges in targeting its context-dependent functions.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты